As we approach the publication of P3 data and Nomis has achieved their goal of being sub 10% ownership - buyers are coming on. The ascending trial is signalling the upward trend. Once it breaks the triangle we'll start fighting the fibs. Once news drops - and we do expect good results throw out the fibs - this is going to rocket. In the mid term we just want to...
